Adastra Pharmaceuticals Announces Positive Top-line Data From Phase 1b Clinical Trial Of Zotiraciclib In The Treatment Of Recurrent High-grade Gliomas

Wine brand

/PRNewswire/ — Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of first-in-class therapeutics for the treatment of…


more on prnewswire.com